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What is known 
1. Certain countries which exhibit a preference for male offspring display 
worryingly skewed sex ratios at birth in favour of baby boys. 
 
2. There has been widespread use of antenatal ultrasound to enable sex 
selective abortion in these countries, now illegal. 
 
3. Non-invasive prenatal tests (based on foetal DNA in maternal blood) are 
currently used (for clinical purposes) in a small number of women whose babies 
are at risk of a sex-linked disorder. 
 
What this paper adds 
1. Direct-to-consumer marketing of non-invasive foetal DNA tests for social sex 
determination became available without sufficient consideration for technical 
performance. 
 
2. Non-invasive foetal sexing is likely to impact sex selection practices in the 
Developing World and Asian Diaspora. 
 
3. Corporate responsibility in marketing tests requires balancing of legitimate 
consumer needs versus unintended consequences. 
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Abstract 
Recent scientific developments in prenatal testing, based on foetal DNA in 
maternal blood, now allow non-invasive foetal sexing early in pregnancies at 
risk of a sex-linked disorder.  In such cases, these novel non-invasive tests can 
improve prenatal care by avoiding invasive procedures like amniocentesis with 
their associated risk of foetal loss.  The tests available for medical use are 
characterised by high accuracy (>99%) and early foetal sex determination (from 
week 7 of gestation).  Many countries now offer families at risk of a sex-linked 
disorder this new form of clinical foetal sexing. 
 
At the same time, further developments in foetal DNA technology are making 
antenatal sex determination possible via a finger-prick sample mailed 
anonymously to a commercial organisation.  Direct marketing to future parents 
of such non-invasive tests for social sex determination will bypass a woman‟s 
physician.  This could allow termination based on sex selection while women 
ostensibly present to physicians, who will have no access to the test result, for a 
termination on social grounds.  If test results are available at 7 weeks gestation, 
online purchase of products for non-surgical abortion at home early in 
pregnancy could also enable some parents to bypass a health system entirely. 
 
Female foeticide, linked to son preference and widespread ultrasound diffusion, 
has already led to significant gender imbalances in India and China.  Certain 
ethnic minority communities in the west are also now displaying evidence of 
foetal sex selection.  Currently, mail-order foetal sexing, based on foetal DNA in 
maternal blood, is still an emerging market.  However, before any widespread 
diffusion, discussion about the implications of this new technology and 
associated issues is important and timely.  This article considers evidence of 
technology development, existing demographic and social changes, corporate 
responsibility in product marketing, and the role of community engagement and 
education. 
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Introduction 
Currently, expectant parents who wish to know their baby‟s sex have to wait for 
a second trimester ultrasound.  While for most there may be no strong gender 
preference and this information simply satisfies their curiosity, there is research 
showing the existence of preferences for an offspring‟s sex in certain 
populations.  Traditionally boys are favoured over girls in China, South Asia and 
Arab countries (Hudson and den Boer, 2005).  There is also evidence of 
antenatal ultrasound being used for sex selection, although originally marketed 
ostensibly to check the health of the foetus.  Reports from India and China 
indicate worryingly skewed sex ratios at birth in favour of baby boys since 
ultrasound was introduced (The Economist, 2010; Lai-wan, 2006; Hudson and 
den Boer, 2005).  In both countries it appears that female infanticide, which 
previously occurred on a relatively small scale, has been replaced by large 
scale sex selective abortion or female foeticide based on the widespread 
availability of this technology (Sheth, 2006; Jha et al, 2006; Aravamudan G, 
2007).  The “50 Million Missing” campaign launched in India in December 2006 
seeks to reduce the loss of girls through foeticide (Banerji R, 2006).  The extent 
to which sex selection is driven by family or cultural preferences and the extent 
to which it is a result of the availability of suitable technology may be debatable, 
but there is clearly a relationship between the two.  Both India and China have 
introduced legislation to attempt to control ultrasound through limiting its 
antenatal use to licensed clinics, but with limited success.  In the developed 
world, although no notable sex imbalance at birth has been reported for the 
majority populations, there is evidence of an effect beginning to emerge in 
South Asian communities in the UK and other countries. 
 
In May 2007, a prenatal home-testing kit to detect a baby‟s sex early in 
pregnancy made headlines in the UK (see: www.dna-worldwide.com).  This test 
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was marketed directly to prospective parents via the internet.  Foetal sex testing 
simply required pregnant women to extract a few drops of blood from their 
finger tip and mail this to a commercial laboratory.  The laboratory testing 
process exploited a new technique for tracing and analysing minute amounts of 
foetal DNA in maternal blood.  This product followed an earlier one which was 
launched in the USA in 2005.  Initially, public demand was reported to be high 
for this product, with more than 1,000 enquiries in the first 3 weeks (Hopkins, 
2005; BMJ News, 2005).  At the same time, several scientists working in the 
field voiced their concerns and recommended caution in terms of the reported 
accuracy of the test (Kaiser, 2005; Bianchi et al, 2006).  The only research 
published using dried drops of maternal blood had suggested that this was less 
reliable than fresh blood (Bischoff et al, 2003; Jorgez et al, 2006). 
 
The development of new non-invasive prenatal diagnostic (NIPD) tests for foetal 
sexing has at first been driven by clinical need in families where a foetus is at 
risk of a sex-linked disorder.  In these cases, a non-invasive test could improve 
clinical care considerably because women would otherwise have to undergo 
invasive amniocentesis or chorionic villus sampling (CVS) to identify whether 
their foetus was affected.  However, wider marketing of NIPD foetal sexing tests 
direct to parents raises a number of concerns.  At first sight, these may appear 
to be only significant in the developing world, but closer consideration shows 
they are also potentially relevant to certain ethnic minority communities in the 
west.  This paper explores some of the issues associated with the technical 
development and direct marketing of NIPD tests.  Because NIPD for foetal 
sexing is still an emerging technology, more widespread discussion of its 
potential use is required. 
 
Clinical drive for NIPD technology development 
Pregnant women whose child is at risk of a sex-linked disorder have, until 
recently, undergone invasive chorionic villus sampling (CVS) for foetal sexing 
from 11 weeks of gestation; however, this procedure carries a 1% risk of 
miscarriage.  Non-invasive prenatal foetal sexing became possible following the 
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discovery of cell-free foetal DNA in maternal plasma (Lo, 1997).  Subsequent 
test development and clinical trials have demonstrated the accuracy of small 
scale testing in individual pregnancies at risk of sex-linked disorders (Avent and 
Chitty, 2006; Hahn et al, 2008).  As a consequence, in the UK and other 
European countries, foetal sexing using NIPD is currently available at a number 
of laboratories at a cost comparable to invasive CVS testing.  NIPD not only 
offers psychological benefits for expecting parents if the test indicates the foetus 
is not prone to a sex-linked disorder, but also the possibility of earlier 
termination if it is prone to a serious disorder (e.g. haemophilia or 
Duchenne/Becker muscular dystrophy), and better management of in utero 
treatment in other cases (e.g. congenital adrenal hyperplasia, a genetic disorder 
that causes girls to develop abnormal male-like characteristics, which can be 
treated with a steroid if identified early in pregnancy).  Sex determination for 
such clinical purposes is based on a venous sample of maternal blood (2.5 ml - 
5 ml). 
 
Because the test relies on sex-dependent markers which are present only in 
males, the NIPD test will give a signal if a male foetus is present and, if no 
signal is observed, a foetus is assumed to be female.  It is, therefore, highly 
dependent on detecting foetal DNA in the blood sample.  In 2004, a National 
Institute of Child Health and Human Development consortium conducted NIPD 
foetal sexing tests in five US centres on samples from 20 pregnant women 
between 10 and 20 weeks of gestation; the recorded sensitivity (the ability to 
detect male DNA when the foetus was male) varied from 31% to 97% across 
centres (Johnson et al, 2004).  More recently, a Dutch study of noninvasive 
foetal sex determination in maternal plasma reported results for 201 pregnant 
women (Scheffer et al, 2010).  The test protocol allowed reporting of a female 
foetus only if the presence of foetal DNA was confirmed; using this protocol, the 
test was able to produce conclusive results in 189 cases, and all of those 
results were correct.  Because trace amounts of DNA are being detected, great 
care is required not to contaminate the sample by male staff handling the test 
materials, which would lead to incorrect identification of a foetus as male. 
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Although NIPD testing is now being used clinically in women carrying an at risk 
foetus, the percentage of pregnancies at risk of sex-linked disorders is 
extremely low.  A potentially much larger market exists world-wide for the social 
use of NIPD foetal sexing to enable parents to discover the sex of their baby 
early in pregnancy.  High throughput laboratory NIPD processes have already 
been developed for detecting foetal rhesus (RhD) blood group which could be 
adapted for mass screening (Finning et al, 2008).  Based on the results of 
published clinical trials, medical sexing should have an accuracy rate of 99.8-
100% if this laboratory protocol is followed (Finning and Chitty, 2008; Avent and 
Chitty, 2006; Hahn et al, 2008).  To date, however, there have been no 
published large scale technical trials reporting test performance using finger-
prick samples.  Expert opinion suggests that the percentage of false negatives 
(i.e. foetus falsely identified as female) will be higher than for venous blood 
samples used for medical purposes (Personal correspondence with Prof. 
Tobias Legler, Universitätsmedizin Göttingen, Germany and Dr. Kirstin Finning, 
National Blood Service, Bristol, UK).  A low signal, due to insufficient foetal 
DNA, would lead to failure to identify the presence of male DNA and therefore 
falsely conclude that the foetus is female.  Sex-independent markers which can 
improve identification of female foetuses are needed to improve accuracy 
(Finning and Chitty, 2008). 
 
Marketing of NIPD tests for foetal sexing 
Marketing of direct-to-consumer foetal DNA tests for sex determination should 
be set within the context of an increased trend towards direct test marketing.  
Recent technological developments have produced a range of tests that can 
either be completed entirely in the home, or that involve self-collection of blood, 
saliva, urine or other specimens which are shipped directly to the manufacturer 
or a reference laboratory for rapid turn-around.  In the USA, the Food and Drug 
Administration (FDA) has cleared a range of over 500 different clinical tests for 
home use and over-the-counter purchase in pharmacies (US Food & Drug 
Administration, 2010).  NIPD foetal sexing tests are not considered suitable for 
 7 
regulation by the FDA or Federal Trade Commission because gender is not a 
clinical condition.  This has theoretically made the path to market much easier 
with some companies stating correctly that their test is FDA cleared (e.g. 
IntelliGender, 2010). 
 
Companies who offer NIPD foetal sexing generally offer testing for £150 to £200 
(e.g.www.babygendermentor.com;www.tellmepinkorblue.com;www.nimblediagn
ostics.co.uk).  This includes the test kit and processing, making the technology 
affordable to a large number of people in both the developed and developing 
world.  At present, however, there is no data available on when, in pregnancy, 
testing is taking place, the level of NIPD uptake in different countries, or 
accuracy rates based on finger prick samples.  Available sources, such as 
comments on users‟ websites, suggest that women send their samples at 
around week eight of gestation.  Users‟ website comments following the launch 
of the first test in the USA also indicated that there appeared to be problems 
with test performance.  This test was initially marketed as 99.9% accurate with a 
200% refund offered if results were incorrect.  An informal web-based poll which 
closed in September 2006 resulted in 97/151 incorrect results being reported 
(Baby Gender Mentor Results Poll, 2007).  Following this, a class action lawsuit 
was filed in the USA suing the company for false advertising and altering their 
money back policy (What‟s New, 2007; Lawsuits & Legal News, 2010).  The 
company filed for chapter 11 bankruptcy in December 2009. 
 
More recently, other US companies which have started to offer a similar service 
are promising a more realistic 95.0% accuracy rate and include instructions for 
males not to handle the kit because this can contaminate the sample leading to 
incorrect identification of a foetus as male (e.g. Pink or Blue, 2010).  Some 
companies also provide a clear statement that they will not market the product 
to India or China, explaining that “due to the high incidence of gender selection 
in China and India, it is our policy not to service these countries. No exceptions 
can be made” (e.g. Pink or Blue, 2010).  In contrast, other companies appear to 
offer a service anywhere in the world. 
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The potential market for non-invasive tests for social sex determination 
encouraged other companies to start offering NIPD tests who subsequently 
suspended marketing (e.g. DNA Worldwide (UK) and Paragon Genetics 
(Canada)).  It is unclear whether this was due to technical problems, fear of 
jeopardising the company‟s image or other reasons.  Recently, in February 
2010, a further company has launched a battery of NIPD tests, including ones 
for determining the sex of a foetus, tests for cystic fibrosis and for foetal Rh-
negative blood incompatibility, all by analysing the mother's blood; the non-
invasive foetal sexing test does not appear to be aimed at social sex 
determination (Sequenom, 2010). 
 
Sex selection practices 
For centuries, sex selection was practised, in the form of infanticide, in certain 
societies and cultures.  However, it is now acknowledged that a preference for 
sons can affect the sex ratio in a country‟s population where there is 
widespread access to prenatal sex selective technology and a reduced fertility 
rate, either by choice as in India (Jha et al, 2006) or by coercion as in China 
(Zhu et al, 2009; Tao and Zhang, 2009; Ding and Hesketh, 2006).  The 
introduction of various technologies has allowed prenatal foetal sex 
determination followed by selective abortion of a foetus of unwanted sex 
(Pallikadavath and Stones, 2006; Aravamudan G, 2007).  Ultrasound, which is 
relatively inexpensive, has been most frequently utilised in the developing 
world, particularly in countries such as India and China (Hesketh and Xing, 
2006).  However, there is some evidence of the use of more invasive and 
expensive procedures such as amniocentesis for sex determination although 
these are ostensibly available primarily for genetic testing (Sharma, 2008).  It 
appears that, in India, male foetuses may be kept following such a procedure 
even if there is evidence of a genetic problem (Hudson and den Boer, 2005).  
Data from India also show that sex selection practices are more common in 
higher birth orders, especially if other children in the family are girls (Dubuc and 
Coleman, 2007; George, 2006).  Currently, although sex selection appears to 
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be practised across all class and income groups in India, there is evidence of 
more extensive use in the economically advantaged or educated middle classes 
than in lower income rural populations (Jha et al, 2006; Pallikadavath and 
Stones, 2006; George, 2006).  There is also a link between decreasing fertility 
and increases in sex selection practices (Hudson and den Boer, 2005). 
 
In general, sex selection, which almost universally favours males, is found in 
societies where the lives of females hold significantly less value than those of 
males.  The reasons for male preference are similar in most cultures and have 
been well described in the literature (Hesketh and Xing, 2006; George, 2006; 
Lai-wan et al, 2006).  In countries such as India and China, although improved 
health care and conditions for women have resulted in reductions in female 
mortality, these advances have been offset by a huge increase in the use of 
sex-selective abortion, which became available in the mid-1980s (The 
Economist 2010).  In India, ratios below 800 females to 1,000 males in the age 
group 0-6 years are now recorded in some areas and it has been estimated 
that, due to sex selection based on prenatal detection, 40-50 million women are 
„missing‟ (George, 2006).  In China, this figure could be as high as 80-100 
million (Hudson and den Boer, 2005).  Numbers continue to grow and all the 
projections are that the gender gap will continue to increase over the coming 
decades.  India, South Korea, China, and most European countries, have laws 
banning foetal sex determination.  In India, the Pre-natal Diagnostics 
Techniques (PNDT) Act came into force in 1996, making it a crime to reveal the 
sex of a foetus.  In 2000, the Supreme Court passed orders to improve 
implementation resulting in most ultrasound clinics being registered; in 2003, a 
further amendment added pre-conception sex selection.  Governments have 
also financed multiple campaigns to encourage families to have girls, promised 
financial rewards and prosecuted physicians who report foetal sex, but these 
actions have not proved successful.  Although doctors have been prosecuted, 
few appear to be convicted (Mudur, 2006).  The resulting surplus of men who 
are unable to find wives is reported to be already creating social problems such 
as an increase in the trafficking of women, selling them into marriage, and 
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forcing increasingly younger girls into marriage (Hudson and den Boer, 2002; 
Hudson and den Boer, 2005; Hesketh and Xing, 2006). 
 
It appears that sex selection in these societies is not only exhibited in practices 
such as prenatal testing and abortion.  There is evidence that, in India and 
China, the deaths of females up to the age of 35 outnumber male deaths 
(Hudson and den Boer, 2005).  This is the reverse of the pattern observed in 
the developed world where girls universally demonstrate higher survival rates.  
Explanations offered for this difference include child neglect, malnourishment, 
and more limited access to medical care for female children.  Also, there is 
some evidence from China and India that, where women themselves choose 
not to have a baby girl, this is so that their female child will not suffer in life as 
much as their mothers; in this way women are trying to protect their unborn 
children from the fate of being a woman in their society (Hudson and den Boer, 
2005). 
 
In addition to prenatal testing, pre-conceptual sex selection through pre-
implantation genetic diagnosis (PGD) has also been utilised in some societies.  
While PGD provides complete accuracy in terms of foetal sex, it is a 
complicated and invasive method requiring in-vitro fertilisation (IVF) and 
hormone therapy preceding IVF.  Not only is IVF expensive, it also has a 
conception success rate of only 25%-50% (Borini et al, 2008).  This procedure 
has been allowed in Israel since 2005 as a means of „family balancing‟ if there 
are already four children of the same sex in the family (Israeli, 2005).  In other 
countries sex selection through PGD is available in private clinics for those 
willing to undergo the procedure.  Sperm sorting, a much simpler method of pre-
conceptual sex selection is not widely used because it is associated with a low 
success rate (Sutton, 2002).  Other methods have been marketed openly for 
sex selection (e.g. GenSelect); these are based on "modifying the body 
chemistries of both mother and father” to help parents influence the gender of 
their next child, although their accuracy has been questioned (CBS News, 
2004). 
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It is worth noting that parents can only hope to select a future child‟s sex but not 
its gender.  Parents cannot predict the sexual orientation of their children when 
they become adults, or the possibilities of them becoming transgender 
individuals (Seavilleklein and Sherwin, 2007).  Although cases when sex differs 
from gender are rare, NIPD technology may be a useful tool for confirming 
foetal sex when there is a suspicion of genital ambiguity on ultrasound (Finning 
and Chitty, 2008). 
 
NIPD markets in India and China 
Currently, sex determination and sex selection practices in India and China 
represent a multimillion dollar business (George, 2006).  NIPD technology for 
foetal sexing could be easily developed in laboratories in these countries at a 
lower cost than in the west.  In India, laboratory testing following amniocentesis 
costs four or ten times less than in the UK and USA respectively (Sen, 2008).  
Technical know-how and the required infrastructure already exist, in India and 
China, through the Special Non-Invasive Advances in Foetal and Neonatal 
Evaluation (SAFE) Network of Excellence which was funded by the European 
Commission Framework 6 Research Programme (2004-09) to speed up the 
development and implementation of NIPD tests.  It is, therefore, reasonable to 
assume that this form of foetal sexing could also eventually be performed at a 
far lower cost than in Europe or the USA.  This would allow widespread 
diffusion of non-invasive foetal sexing via Indian and Chinese laboratories. 
 
Widespread availability will mean that parents in countries where sex selection 
is already being practiced via ultrasound clinics could order a test online, post a 
blood sample, and receive results without their medical practitioner being 
aware.  Women may then present to a physician, who has no access to the test 
result, for a termination ostensibly on social grounds.  Alternatively, because the 
NIPD test allows for early termination, products could be purchased online for 
non-surgical abortion at home during the first few weeks of pregnancy (e.g. 
http://www.abortion-pill-online.com). 
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NIPD markets in western countries 
In the western world, some communities, such as the Hispanics in the USA and 
South America and populations in certain European countries, appear to exhibit 
a slightly higher preference for girls, although this gender preference is 
dependent on the number and sex of existing children in the family (van Balen, 
2006).  Other migrant ethnic minority populations in the US, such as Asians and 
Arabs, show a preference for boys, although not to the same extent as reported 
in their home countries (van Balen, 2006).  More recently, male-biased sex 
ratios have been documented among US-born children of Chinese, Korean, and 
Asian Indian parents, with the male bias particularly evident for later children; if 
there was no previous male child, sons outnumbered daughters by 50% 
(Almond and Edlund, 2008).  In Norway, a recent study reported significantly 
lower female-to-male sex ratios in higher order births to mothers of Indian origin 
who gave birth after 1987; no such effect is observable for parents of Pakistani 
origin (Singh et al 2010).  In England and Wales, a similar study has reported 
that, between 1990 and 2005, almost 1,500 fewer girls were born to Indian 
mothers; there was a four-point increase in the sex ratio at birth for mothers 
born in India, attributable particularly to an increase at higher birth orders, 
mirroring findings reported for India (Dubuc and Coleman, 2007).  No significant 
increase was observed for Pakistan-born and Bangladesh-born mothers, 
among whom male preference presumably also exists.  However, no evidence 
was presented to show why these South Asian sub-groups differ. 
 
While the western world has not shown any predisposition towards sex 
selection practice following the development of antenatal ultrasound, it does not 
mean that NIPD introduction will not be pursued as a business opportunity.  
There is currently no firm evidence that NIPD test kits are being purchased for 
sex selection in the west; instead, online forum comments (www.in-gender.com) 
suggest that they are being used for social reasons with parents purchasing kits 
because they want to know the sex of their future baby before the second 
trimester ultrasound.  Rationales given include a desire to “share the news”, 
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“decorate the room”, “buy baby clothes” and “to bond with their future child”.  It 
is perhaps not surprising that women are not prepared to discuss sex selection 
in an open online forum.  However, comments from a small number of women 
suggest that they might consider a termination if the foetus were of the “same 
sex as previous children in the family”. 
 
In the UK, most terminations (89%) are carried out before 13 weeks of gestation 
(Department of Health, 2007).  If sex determination through ultrasound is 
performed in the second trimester, this makes it more difficult to contemplate 
abortion for sex selection reasons.  However, there is anecdotal evidence that 
some pregnant Indian-born women, under family pressure to have sons, are 
travelling to India to abort their unborn daughters (BBC, 2007).  In contrast, 
since the new NIPD test can be performed as early as 7 weeks of gestation, 
parents who order an NIPD kit would be able to make an appointment at a clinic 
to terminate the pregnancy for „social reasons‟ without leaving the country. 
 
Key issues for NIPD foetal sexing 
A number of issues need to be addressed in advance of the widespread 
availability of accurate NIPD technology.  Cultural and perceived economic 
reasons cannot be underestimated as continuing drivers for sex selection and 
both will be difficult to change, in both host and immigrant communities living in 
the west.  Studies are necessary to understand whether public education 
campaigns can be effective in the west.  In India, it appears that education of 
women does not have a noticeable impact on attitudes towards sex selection; 
males continue to be preferred as better providers for their parents in old age 
(Hudson and den Boer, 2005).  Nevertheless, change is possible.  In South 
Korea, for instance, the trend of boy preference has been reversed with the 
growth in economic prosperity (Lee, 2007).  Important factors appear to include 
men moving to the cities for higher paying jobs and leaving their parents behind, 
combined with the rising income of older Koreans which allows them to save 
money for their retirement.  Although such changes have been influential in a 
small country like Korea experiencing an economic boom, it is uncertain 
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whether, in much larger territories such as China and India, economic 
improvement will shift the paradigm of son-preference.  The extent to which 
behaviour is carried over after immigration in different population groups is not 
clear, neither are the reasons for any differences.  More research is needed to 
assess the attitudes of first and second generation ethnic minority women and 
families in the west, especially those going through a third or fourth pregnancy.  
Last, but perhaps most importantly, a dialogue should be initiated with 
companies marketing non-invasive tests for social sex determination.  More 
transparency is required in terms of where test markets are being developed 
and how corporate responsibility can be encouraged in the marketing of these 
tests so that legitimate consumer needs are met without the danger of 
unintended consequences. 
 
In the literature, discussion to date related to technology use in sex selection 
has primarily focused on PGD and sperm sorting when considering the western 
world and the use of ultrasound in the developing world (Sutton, 2002; Hall and 
Marteau, 2006; Newiss, 2006; Thomas, 2007; Baldwin, 2006; Courtwright, 
2008; Seavilleklein and Sherwin, 2007).  Authors are now starting to address 
NIPD for foetal sexing with a number of potential ethical concerns being raised 
(Newson, 2008; Smith et al, 2006; Guetta, 2006; Hyett et al, 2005).  However, 
commercial developments are moving ahead with NIPD tests now emerging for 
other foetal characteristics such as foetal RhD blood, status inherited single 
gene recessive disorders like haemoglobinopathies, and Downs syndrome.  It is 
likely that these NIPD tests will initially be carried out under the direction of a 
physician.  However, with the increased trend towards marketing home-testing 
kits, combined with parents‟ interest in the health of their unborn child, it is not 
impossible that such NIPD tests may also eventually be marketed direct to 
parents. 
 
Conclusions 
The broad socio-economic issues outlined above need to be addressed before 
direct-to-consumer marketing of NIPD tests for foetal sexing becomes 
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widespread.  Key questions are: how to control their use in the developing 
world, how to influence their use in the Asian Diaspora, what means will 
encourage corporate responsibility, and how to maximise community 
engagement in the process. 
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